Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Antibiotic-Resistant Germs Could Kill 10M Every Year By 2050: Report December 16, 2014 Martha Garcia Add Your Comments A new report commissioned by the British government warns that we may see 10 million deaths attributable to antibiotic resistant infections every year by 2050, unless drastic measures are taken to mitigate the growing risks caused by over-use of the medications. The data comes from a study commissioned by the U.K.’s Prime Minister, which called for a review on antibiotic resistant bacteria in July. The study was conducted by two separate research teams from RAND Europe and KPMG, which examined existing studies. The Review on Antimicrobial Resistance report is based on the initial findings of the two research teams of British health experts, led by Jim O’Neill, former chief economist of Goldman Sachs. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers focused on three of seven drug resistant bacteria identified by the World Health Organization (WHO), which have already begun showing resistance levels and pose a concern to public health. Included were Klebsiella pneumonia, Escherichia coli (E. coli) and Staphylococcus aureus. The report estimates that by 2050 more than 10 million deaths each year will be attributed to antibiotic resistant bacteria. This dwarves the estimates projected for other diseases, including cancer at 8.2 million, diabetes at 1.5 million, tetanus at 60,000 and other deaths attributable to traffic accidents at 1.2 million. Overall, researchers call the situation a global “crisis” and estimate it will cost up to $100 trillion, resulting in a decline of the global gross domestic product (GDP) by 2 to 3.5 percent by 2050. While antibiotics began as one of the top medical discoveries to revolutionize medicine and treat deadly disease, many strains of bacteria and other pathogens have now evolved to resist the drugs. Surgeries that have become widespread and low-risk, due to antibiotics and advanced medicine technology, could again become dangerous to patients because of antibiotic resistant bacteria. “Resistance has increasingly become a problem in recent years because the pace at which we are discovering novel antibiotics has slowed drastically, while antibiotic use is rising,” wrote study authors. Antibiotic Global Concerns The report concludes that resistance is a problem which will affect nations globally. The researchers predict Asia will have the highest number of deaths attributable to antibiotic resistance at 4.7 million, Africa will have an estimated 4.1 million deaths, and Europe and the U.S. will see 390,000 and 317,000 deaths, respectively. Currently, the worldwide death toll from antibiotic resistant infections is at about 700,000, with 50,000 lives lost each year across both Europe and the U.S. “In 15 European countries more than 10 percent of bloodstream Staphylococcus aureus infections are caused by methicillin-resistant strains (MRSA), with several of these countries seeing resistance rates closer to 50 percent,” wrote study authors. A study published recently in the journal Medical Decision Making found part of a doctor’s reason for prescribing antibiotics is a patient’s insistence and expectation to receive the drugs, even if they have a viral infection. Patients often believe taking antibiotics may help their illness, and if it doesn’t, in their mind, at least it will not worsen the illness. The study revealed that overall patients tend to think the risk of taking unnecessary antibiotics is not greater than the help it may give them, despite educational materials offered at their doctor’s office that say otherwise. Global consumption of antibiotics in human medicine rose 40% between 2000 to 2010. Researchers estimate nearly 480,000 new cases of drug resistant strains of tuberculosis were seen in 2013, the majority went untreated. Despite the high numbers presented by the data, the researchers caution that the report is not a full picture of the problem. The report only focused on a few strains of bacteria. They also reported other health issues may also pose a threat, including HIV, tuberculosis and malaria. They cited malaria resistance as leading to the greatest numbers of fatalities. Researchers said several things need to be focused on to stop this problem from growing out of control. They highlighted a need to change the use of antibiotics by doctors to reduce resistance, a need to boost development of new antibiotics, a new focus on alternative therapies to disrupt the rise of resistance, and a need for international action that spans drug regulation and drug use across humans, animals and the environment. Tags: Antibiotics, Bacterial Contamination, Infection More Lawsuit Stories Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 July 8, 2025 Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling July 8, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)